Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery?
Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, China.
Kai Yun
KY
You
Yuan Hong
YH
Gao
D000230:Adenocarcinoma / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000473:pathology* / Q000628:therapy*; D018365:Neoplasm, Residual / Q000473:pathology* / Q000628:therapy*; D012004:Rectal Neoplasms / Q000473:pathology* / Q000628:therapy*